The percentage of compliant continuous positive airway pressure (CPAP)-treated apnoeic
patients that continue to experience residual excessive sleepiness (RES) is unknown. RES …

We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

Some patients with obstructive sleep apnoea syndrome (OSAS; respiratory distress index
(RDI) of> 5 events· h− 1) experience residual excessive daytime subjective sleepiness …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Excessive daytime sleepiness (EDS) is a symptom of obstructive sleep apnea (OSA) that
resolves under treatment with continuous positive airway pressure (CPAP). In some patients …

Hypoxic brain damage might explain persistent sleepiness in some continuous positive
airway pressure‐compliant obstructive sleep apnea called residual excessive sleepiness …

The aim of this study was to investigate in a large population of patients with obstructive
sleep apnoea and on long-term treatment with continuous positive airway pressure (CPAP) …

OBJECTIVE: We sought to determine the clinical implications, predictors and patterns of
residual sleep apnea on continuous positive airway pressure (CPAP) treatment in patients …

Continuous positive airway pressure (CPAP) remains the best treatment for sleep apnoea
syndrome (SAS). In the 1990s, many authors reported on daily compliance, but all of the …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …